« Return to News | CROs/Service Providers

PRA expands operations in the Netherlands and U.K.

Monday, May 21, 2012 03:48 PM

PRA, a global CRO, is expanding its operations in the Netherlands and the U.K. to accommodate staff growth and strong client demand for its phase IIa-IIIb service offerings.

Located in Utrecht, Netherlands, the new Dutch facility will host 20+ employees and is the first PRA office in that region to primarily support product registration trials. Previously, production registration staff members in the Netherlands worked remotely from home or the Mechelen, Belgium office.

“We felt that it was now necessary to provide a permanent office for the increasing Dutch product registration team,” said Frank van de Wijngaert, vice president and general partner, PRA.

Also this month, PRA’s 240+ employees in Reading, U.K., relocated to a larger, PRA-designed facility that offers additional room for increasing headcounts and provides modern facilities for client and project team meetings. The location also offers a first-class business park environment with excellent transportation links.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.